Cargando…

A systematic review of randomized controlled trials of the Wenyang Huoxue method in treating diabetic peripheral neuropathy

OBJECTIVE: To assess the efficacy and safety of the Wenyang Huoxue method for patients with diabetic peripheral neuropathy. METHODS: A systematic literature search was performed using 7 databases: PUBMED, EMBASE, the Chinese National Knowledge Infrastructure, Wanfang, Chinese BioMedical, and the VIP...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Zhiyuan, Wang, Manjia, Fan, Yao-hua, Huang, Ruilin, Rao, Yawen, Mai, Xurong, Liu, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824654/
https://www.ncbi.nlm.nih.gov/pubmed/31626140
http://dx.doi.org/10.1097/MD.0000000000017618
_version_ 1783464769624211456
author Deng, Zhiyuan
Wang, Manjia
Fan, Yao-hua
Huang, Ruilin
Rao, Yawen
Mai, Xurong
Liu, Min
author_facet Deng, Zhiyuan
Wang, Manjia
Fan, Yao-hua
Huang, Ruilin
Rao, Yawen
Mai, Xurong
Liu, Min
author_sort Deng, Zhiyuan
collection PubMed
description OBJECTIVE: To assess the efficacy and safety of the Wenyang Huoxue method for patients with diabetic peripheral neuropathy. METHODS: A systematic literature search was performed using 7 databases: PUBMED, EMBASE, the Chinese National Knowledge Infrastructure, Wanfang, Chinese BioMedical, and the VIP Chinese Science and Technique Journals. The publication time was from the start of each database up to November 2018. Review Manager 5.3 software was used for assessing potential bias, data synthesis, and the subgroup analysis. Begg and Egger tests were used to assess funnel plot symmetries using Stata 14.0 software. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) system was used to assess the quality of evidence. RESULTS: A total of 22 trials involving 1835 participants were eligible. There were significant differences in a total effective rate between the Wenyang Huoxue method combined with Western medicine and Western medicine alone (RR = 1.33, 95% CI 1.26–1.41; P < .00001). As for the sensory conduction velocity (SCV) of the peroneal nerve, the Wenyang Huoxue method combined with Western medicine compared with Western medicine alone had a significant increase (weighted mean difference [WMD] = 5.00, 95% CI 3.42–6.57; P < .00001). Also, the Wenyang Huoxue method combined with Western medicine had significant increases in motor conduction velocity (MCV) of the peroneal nerve (WMD = 4.48, 95% CI 3.78–5.19; P < .00001), tibial nerve SCV (WMD = 3.47, 95% CI 2.66–4.28; P < .00001), tibial nerve MCV (4.87, 95% CI 3.21–6.53; P < .00001), median nerve SCV (WMD = 3.78, 95% CI 3.07–4.50; P < .00001), and median nerve MCV (WMD = 4.50, 95% CI 3.40–5.59; P < .00001). However, the effect of the Wenyang Huoxue method on fasting blood glucose, 2-h postprandial blood glucose, and glycosylated hemoglobin was not statistically significant. Egger's test results showed that there was no publication bias (P = .0008), but the trim and filling method showed steady results. An influence analysis showed that no single study affected the overall result. The GRADE quality of the evidence was low to moderate across the different outcomes. CONCLUSION: Despite of the apparently positive findings, the quality of GRADE is not high, suggesting that the Wenyang Huoxue method can improve nerve conduction velocity to a certain extent, but more rigorous literature is needed to support this evidence.
format Online
Article
Text
id pubmed-6824654
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-68246542019-11-19 A systematic review of randomized controlled trials of the Wenyang Huoxue method in treating diabetic peripheral neuropathy Deng, Zhiyuan Wang, Manjia Fan, Yao-hua Huang, Ruilin Rao, Yawen Mai, Xurong Liu, Min Medicine (Baltimore) 3800 OBJECTIVE: To assess the efficacy and safety of the Wenyang Huoxue method for patients with diabetic peripheral neuropathy. METHODS: A systematic literature search was performed using 7 databases: PUBMED, EMBASE, the Chinese National Knowledge Infrastructure, Wanfang, Chinese BioMedical, and the VIP Chinese Science and Technique Journals. The publication time was from the start of each database up to November 2018. Review Manager 5.3 software was used for assessing potential bias, data synthesis, and the subgroup analysis. Begg and Egger tests were used to assess funnel plot symmetries using Stata 14.0 software. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) system was used to assess the quality of evidence. RESULTS: A total of 22 trials involving 1835 participants were eligible. There were significant differences in a total effective rate between the Wenyang Huoxue method combined with Western medicine and Western medicine alone (RR = 1.33, 95% CI 1.26–1.41; P < .00001). As for the sensory conduction velocity (SCV) of the peroneal nerve, the Wenyang Huoxue method combined with Western medicine compared with Western medicine alone had a significant increase (weighted mean difference [WMD] = 5.00, 95% CI 3.42–6.57; P < .00001). Also, the Wenyang Huoxue method combined with Western medicine had significant increases in motor conduction velocity (MCV) of the peroneal nerve (WMD = 4.48, 95% CI 3.78–5.19; P < .00001), tibial nerve SCV (WMD = 3.47, 95% CI 2.66–4.28; P < .00001), tibial nerve MCV (4.87, 95% CI 3.21–6.53; P < .00001), median nerve SCV (WMD = 3.78, 95% CI 3.07–4.50; P < .00001), and median nerve MCV (WMD = 4.50, 95% CI 3.40–5.59; P < .00001). However, the effect of the Wenyang Huoxue method on fasting blood glucose, 2-h postprandial blood glucose, and glycosylated hemoglobin was not statistically significant. Egger's test results showed that there was no publication bias (P = .0008), but the trim and filling method showed steady results. An influence analysis showed that no single study affected the overall result. The GRADE quality of the evidence was low to moderate across the different outcomes. CONCLUSION: Despite of the apparently positive findings, the quality of GRADE is not high, suggesting that the Wenyang Huoxue method can improve nerve conduction velocity to a certain extent, but more rigorous literature is needed to support this evidence. Wolters Kluwer Health 2019-10-18 /pmc/articles/PMC6824654/ /pubmed/31626140 http://dx.doi.org/10.1097/MD.0000000000017618 Text en Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 3800
Deng, Zhiyuan
Wang, Manjia
Fan, Yao-hua
Huang, Ruilin
Rao, Yawen
Mai, Xurong
Liu, Min
A systematic review of randomized controlled trials of the Wenyang Huoxue method in treating diabetic peripheral neuropathy
title A systematic review of randomized controlled trials of the Wenyang Huoxue method in treating diabetic peripheral neuropathy
title_full A systematic review of randomized controlled trials of the Wenyang Huoxue method in treating diabetic peripheral neuropathy
title_fullStr A systematic review of randomized controlled trials of the Wenyang Huoxue method in treating diabetic peripheral neuropathy
title_full_unstemmed A systematic review of randomized controlled trials of the Wenyang Huoxue method in treating diabetic peripheral neuropathy
title_short A systematic review of randomized controlled trials of the Wenyang Huoxue method in treating diabetic peripheral neuropathy
title_sort systematic review of randomized controlled trials of the wenyang huoxue method in treating diabetic peripheral neuropathy
topic 3800
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824654/
https://www.ncbi.nlm.nih.gov/pubmed/31626140
http://dx.doi.org/10.1097/MD.0000000000017618
work_keys_str_mv AT dengzhiyuan asystematicreviewofrandomizedcontrolledtrialsofthewenyanghuoxuemethodintreatingdiabeticperipheralneuropathy
AT wangmanjia asystematicreviewofrandomizedcontrolledtrialsofthewenyanghuoxuemethodintreatingdiabeticperipheralneuropathy
AT fanyaohua asystematicreviewofrandomizedcontrolledtrialsofthewenyanghuoxuemethodintreatingdiabeticperipheralneuropathy
AT huangruilin asystematicreviewofrandomizedcontrolledtrialsofthewenyanghuoxuemethodintreatingdiabeticperipheralneuropathy
AT raoyawen asystematicreviewofrandomizedcontrolledtrialsofthewenyanghuoxuemethodintreatingdiabeticperipheralneuropathy
AT maixurong asystematicreviewofrandomizedcontrolledtrialsofthewenyanghuoxuemethodintreatingdiabeticperipheralneuropathy
AT liumin asystematicreviewofrandomizedcontrolledtrialsofthewenyanghuoxuemethodintreatingdiabeticperipheralneuropathy
AT dengzhiyuan systematicreviewofrandomizedcontrolledtrialsofthewenyanghuoxuemethodintreatingdiabeticperipheralneuropathy
AT wangmanjia systematicreviewofrandomizedcontrolledtrialsofthewenyanghuoxuemethodintreatingdiabeticperipheralneuropathy
AT fanyaohua systematicreviewofrandomizedcontrolledtrialsofthewenyanghuoxuemethodintreatingdiabeticperipheralneuropathy
AT huangruilin systematicreviewofrandomizedcontrolledtrialsofthewenyanghuoxuemethodintreatingdiabeticperipheralneuropathy
AT raoyawen systematicreviewofrandomizedcontrolledtrialsofthewenyanghuoxuemethodintreatingdiabeticperipheralneuropathy
AT maixurong systematicreviewofrandomizedcontrolledtrialsofthewenyanghuoxuemethodintreatingdiabeticperipheralneuropathy
AT liumin systematicreviewofrandomizedcontrolledtrialsofthewenyanghuoxuemethodintreatingdiabeticperipheralneuropathy